Table I.
Clinical data of the subjects.
| Control (n=5) | Organ-confined Pca (n=11) | Advanced Pca without cachexia (n=15) | Advanced Pca with cachexia (n=8) | |
|---|---|---|---|---|
| Age (years) | 49.4±3.3 | 64.2±2.1 | 70.7±2.0 | 71.4±2.9 |
| Radical prostectomy | 10 | |||
| Hormone therapy | 1 | 15 | 8 | |
| Stage I | 11 | |||
| Stage IV | 15 | 8 | ||
| Total serum protein (g/dl) | 7.4±0.2 | 7.2±0.1 | 6.3±0.2 | 5.6±0.3a |
| Serum albumin (g/dl) | 4.1±0.1 | 4.3±0.1 | 3.5±0.1 | 2.7±0.2a |
| Hb (104/μl) | 14.2±0.5 | 14.3±0.5 | 10.4±0.6a | 8.8±1.0a |
| PSA (ng/ml) | 1.7±0.5 | 11.6±3.0 | 1,206.2±374.0a | 1,390.5±705.6a |
| Life expectancy | All alive | All alive | 8.4 months | 1.2 months |
Pca, prostate carcinoma.
a
p<0.05 vs. control or organ-confined Pca. Data are expressed as the means ± SE. Details of the statistical method are described in the text.